Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / *W EXP 08/27/202
-
Total 13F shares
-
900,997
-
Share change
-
+262,259
-
Total reported value
-
$1,260,554
-
Price per share
-
$1.39
-
Number of holders
-
11
-
Value change
-
+$410,639
-
Number of buys
-
7
-
Number of sells
-
2
Institutional Holders of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) as of Q2 2024
As of 30 Jun 2024,
Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
900,997 shares.
The largest 10 holders included
LPL Financial LLC, CSS LLC/IL, METEORA CAPITAL, LLC, COWEN AND COMPANY, LLC, WOLVERINE ASSET MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, JANE STREET GROUP, LLC, Sio Capital Management, LLC, Privium Fund Management B.V., and UBS Group AG.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.